What is Bicara Therapeutics's other income (expense)?

Bicara Therapeutics (BCAX) reported other income (expense) of $4.08M in Q1 2026.

How has Bicara Therapeutics's other income (expense) changed year-over-year?

Bicara Therapeutics's other income (expense) decreased by 18.6% year-over-year, from $5.01M to $4.08M.

What does other income (expense) mean?

Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Bicara Therapeutics BCAX Other Income (Expense)

Other Income (Expense) at other companies

Eli LillyLLY

-$65M+72.8%

AmgenAMGN

$75M-95.1%

Arcus BiosciencesRCUS

$6M-40.0%

Syndax PharmaceuticalsSNDX

-$8.47M-678%

Nuvation BioNUVB

$1.52M-73.7%

Viridian Therapeutics, Inc.VRDN

$11.27M+62.0%

Segments

By segment

See full

Reportable Segment$4.08M-18.6%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.64B+81.4%

Enterprise value$1.32B+288%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's other income (expense)?: Bicara Therapeutics (BCAX) reported other income (expense) of $4.08M in Q1 2026.
How has Bicara Therapeutics's other income (expense) changed year-over-year?: Bicara Therapeutics's other income (expense) decreased by 18.6% year-over-year, from $5.01M to $4.08M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.